Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
34.40    0.50 (1.47%)
Bid:
34.40
Ask:
34.95
Spread: 0.55 (1.599%)
Market Cap: £101.58m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Progressive publishes new research

23 Nov 2021 07:57

RNS Number : 2502T
Severfield PLC
23 November 2021
 

Small H1 'beat' despite supply chain challenge

 

Strong trading and a new record high for the order book for Britain's leading structural steel specialist drove a 22% increase in adjusted interim PBT, slightly exceeding its previous guidance on the H1:H2 split. This underpins our FY2022E forecasts, which we are not changing at this point, while the 37% Y/Y increase in orders provides increased visibility through to FY2023E. The strong first-half performance was achieved despite supply chain and inflationary pressures in the UK, while the Indian JV returned to profitability amid clear signs of economic recovery from Covid.

 

Click here for full analysis

 

Subscribe to Progressive's research, which is freely available to every type of investor, and be kept informed about our regular programme of investor engagement. 

About Progressive:

 

Progressive is an equity research and investor engagement company. FCA authorised and regulated, the firm has a 15-strong team of highly experienced analysts. We provide Institutional grade research and connect companies with investors across every sector of the market.

 

www.progressive-research.com

 

Broad coverage

 

Analyst calibre

 

across 12 sectors

 

 

 

 

 

 

Business Services

Oil & Gas

15analysts

with average

20years

Financials

Property

experience of

Healthcare

Retail

Industrials

Technology

30+

techMARK

Investment Trusts

Telecoms

industry based

Extel

Mining

Utilities

awards

StarMine

 

 

For further information please contact:

 

Keith Hodgskiss

+44 (0) 20 7781 5315

khodgskiss@progressive-research.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPPGAAGUPGUMW
Date   Source Headline
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.